Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1 - Tabular View

Tracking Information

First Received Date ^ICMJE

February 19, 2004

Last Updated Date

July 28, 2008

Start Date ^ICMJE

October 2003

Primary Completion Date

April 2006 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Treatment Utilization
Substance Abuse

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00078143 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1

Official Title ^ICMJE

Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users

Brief Summary

The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.

Detailed Description

Study Phase

Phase III

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment

Condition ^ICMJE

Substance-Related Disorders

Intervention ^ICMJE

Behavioral: Behavior Therapy

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

200

Completion Date

April 2006

Primary Completion Date

April 2006 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Pregnancy <30 weeks
Have not attended drug treatment in past 28 days
Not needing residential treatment (except detox)
Not at risk for suicide/homicide
Have no pending legal charges (except drug treatment)

Gender

Female

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00078143

Responsible Party

Study ID Numbers ^ICMJE

NIDA-CTN-0013-1

Study Sponsor ^ICMJE

National Institute on Drug Abuse (NIDA)

Collaborators ^ICMJE

University of Minnesota

Investigators ^ICMJE

Principal Investigator:

Theresa Winhusen, Ph.D.

University of Cincinnati

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

July 2008

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP